96 Participants Needed

Mindfulness-Based Education for Type 2 Diabetes

CA
Overseen ByCaroline A Presley, MD, MPH
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Alabama at Birmingham
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Diabetes distress is common affecting over one-third of people with type 2 diabetes, negatively impacting self-management and outcomes, and disproportionately affecting low-income individuals. The proposed project will conduct a pilot randomized controlled trial comparing Mindfulness-Based Diabetes Education to standard Diabetes Self-Management Education in adults with type 2 diabetes and elevated diabetes distress who receive care within safety-net healthcare systems in order to assess feasibility and acceptability.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your current diabetes treatment, but you should confirm with the trial organizers.

Is mindfulness-based education safe for people with type 2 diabetes?

Mindfulness-based education, such as Mindfulness-Based Stress Reduction (MBSR) and Mindfulness-Based Cognitive Therapy (MBCT), has been studied in people with diabetes and is generally considered safe. Participants in these studies reported high satisfaction and no significant safety concerns were noted.12345

How does the treatment Mindfulness-Based Diabetes Education differ from other treatments for type 2 diabetes?

Mindfulness-Based Diabetes Education is unique because it focuses on reducing stress and improving mental health through mindfulness practices, which can enhance diabetes self-management and reduce diabetes-related distress. Unlike traditional treatments that primarily target blood sugar levels, this approach emphasizes mental well-being and self-awareness to support overall diabetes care.15678

What data supports the effectiveness of the treatment Mindfulness-Based Diabetes Education for Type 2 Diabetes?

Research shows that mindfulness-based interventions, like Mindfulness-Based Stress Reduction (MBSR), can significantly reduce diabetes-related stress and improve self-management behaviors. Studies also found improvements in diabetes distress, self-efficacy, and A1C levels, indicating better blood sugar control.12359

Who Is on the Research Team?

CA

Caroline A Presley, MD, MPH

Principal Investigator

University of Alabama at Birmingham

Are You a Good Fit for This Trial?

This trial is for adults with type 2 diabetes who are experiencing high levels of stress related to their condition. Participants must be 19 or older, have a hemoglobin A1c level of at least 7.5%, and show moderate to severe distress on the Diabetes Distress Scale. They should also be receiving care from specific healthcare systems and not have severe psychiatric conditions like bipolar disorder or schizophrenia.

Inclusion Criteria

I am 19 years old or older.
I have been diagnosed with type 2 diabetes.
You are feeling very stressed about having diabetes.
See 2 more

Exclusion Criteria

Currently pregnant
I have been diagnosed with a severe psychiatric condition like bipolar disorder, schizophrenia, or have had psychosis.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Treatment

Participants receive either Mindfulness-Based Diabetes Education or standard Diabetes Self-Management Education in 8 weekly group sessions followed by 2 bimonthly individual sessions

6 months
8 weekly group sessions, 2 bimonthly individual sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessments at baseline, 2 months, and 6 months

6 months
3 visits (in-person) at baseline, 2 months, and 6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Mindfulness-Based Diabetes Education
  • Standard Diabetes Self-Management Education (DSME)
Trial Overview The study is testing Mindfulness-Based Diabetes Education against the standard Diabetes Self-Management Education in people with type 2 diabetes who are under a lot of stress because of their illness. It aims to see which method is more feasible and acceptable within low-income healthcare settings.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Mindfulness-Based Diabetes EducationExperimental Treatment1 Intervention
Group II: Standard Diabetes Self-Management EducationActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alabama at Birmingham

Lead Sponsor

Trials
1,677
Recruited
2,458,000+

Published Research Related to This Trial

The Mindful Stress Reduction in Diabetes Education (Mind-STRIDE) program, a mindfulness-based intervention for veterans, showed high satisfaction rates among participants and educators, with 71% of veterans completing the study.
Participants experienced significant improvements in diabetes-related outcomes, including reduced diabetes distress and better self-management behaviors, suggesting that mindfulness practices can positively impact diabetes management.
A Mindful Approach to Diabetes Self-Management Education and Support for Veterans.DiNardo, M., Saba, S., Greco, CM., et al.[2022]
In a study with 38 participants, mindfulness-based stress reduction (MBSR) significantly decreased diabetes-related distress and improved glucose control, indicating its potential as an effective intervention for diabetes management.
Participants also experienced notable improvements in mental health factors such as depression, anxiety, and self-efficacy, suggesting that MBSR can enhance both diabetes management and overall well-being.
Reducing diabetes distress and improving self-management with mindfulness.Whitebird, RR., Kreitzer, MJ., Vazquez-Benitez, G., et al.[2022]
Mindfulness-based interventions (MBIs) significantly reduce diabetes distress in adults, especially for those with high baseline distress, showing a moderate effect size of 0.48 based on a review of 10 studies with 649 participants.
The most effective MBIs were those based on mindfulness-based stress reduction therapy, delivered in group formats, and including home practice assignments, with long-term effects showing a large effect size of 0.56.
Factors influencing the effect of mindfulness-based interventions on diabetes distress: a meta-analysis.Guo, J., Wang, H., Luo, J., et al.[2023]

Citations

A Mindful Approach to Diabetes Self-Management Education and Support for Veterans. [2022]
Reducing diabetes distress and improving self-management with mindfulness. [2022]
Factors influencing the effect of mindfulness-based interventions on diabetes distress: a meta-analysis. [2023]
Comparison of the effects of Korean mindfulness-based stress reduction, walking, and patient education in diabetes mellitus. [2015]
Effects of Mindfulness-Based Stress Reduction and Mindfulness-Based Cognitive Therapy in People With Diabetes: A Systematic Review and Meta-Analysis. [2021]
Effectiveness of a nurse-led mindfulness stress-reduction intervention on diabetes distress, diabetes self-management, and HbA1c levels among people with type 2 diabetes: A pilot randomized controlled trial. [2022]
Intervention Effect of Mindfulness-Based Cognitive Therapy on Diabetes-Related Distress and Self-Care. [2022]
The effectiveness of mindfulness-based stress reduction (MBSR) on the mental health, HbA1C, and mindfulness of diabetes patients: A systematic review and meta-analysis of randomised controlled trials. [2023]
Evaluation of the Effects of 12 Weeks Mindfulness-Based Stress Reduction on Glycemic Control and Mental Health Indices in Women with Diabetes Mellitus Type 2. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security